Background illustration for clinical trials search

Lung Cancer Clinical Trials

Browse 2,144 lung cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

A Study of Sotorasib in People With Non-Small Cell Lung Cancer

for
Non Small Lung Cancer
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT06582771

Phase 2, Recruiting

Tumor Immunotherapy and Microbiome Analysis

for
Advanced Solid Tumor
Location: Toronto
Sponsor: Sunnybrook Health Sciences Centre

Sex: All

Age: 18+

Code: NCT04579978

Recruiting

Dose-escalation Study of Oral CX-4945

for
Advanced Solid Tumors, Breast Cancer,
Location: Houston TX, Fort Collins CO, Loveland CO, Scottsdale AZ
Sponsor: Cylene Pharmaceuticals

Sex: All

Age: 18+

Code: NCT00891280

Phase 1, Recruiting

A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body

for
Melanoma, Clear-Cell Renal-Cell Carcinoma (ccRCC),
Location: North Haven CT, Lake Success NY, Chapel Hill NC,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06413680

Phase 1, Phase 2, Recruiting

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

for
Non-Small Cell Lung Cancer (NSCLC)
Location: Halifax, Worcester MA, Montreal, Media PA, Newark DE,
Sponsor: Amgen

Sex: All

Age: 18 - 70+

Code: NCT05920356

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Neoadjuvant Dupilumab and Cemiplimab in Patients With Early-stage Resectable NSCLC

for
Non-Small Cell Lung Cancer
Location: New York NY
Sponsor: Icahn School of Medicine at Mount Sinai

Sex: All

Age: 18+

Code: NCT06088771

Phase 1, Phase 2, Recruiting

Evaluation of Technological Innovation in Radiotherapy

for
Cancer, Radiotherapy Side Effect
Location: Quebec, Montreal, Laval, Toronto, London, Kelowna,
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Sex: All

Age: 18+

Code: NCT03378856

Recruiting

A Study of RX108 in Patients With Locally Advanced or Metastatic Solid Tumors

for
Locally Advanced Solid Tumors, Metastatic Solid Tumors
Location: Houston TX, Los Angeles CA
Sponsor: NeuPharma, Inc.

Sex: All

Age: 18+

Code: NCT03646071

Phase 1, Recruiting

Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors

for
Unspecified Adult Solid Tumor, Protocol Specific,
Location: Winston-Salem NC
Sponsor: Wake Forest University Health Sciences

Sex: All

Age: 18 - 70+

Code: NCT00900471

Recruiting

Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer

for
Non-Small Cell Lung Cancer
Location: Ocoee FL, Tyler TX, Dallas TX, Spokane WA, Seattle WA
Sponsor: Corixa Corporation

Sex: All

Age: 18+

Code: NCT00062907

Phase 1, Recruiting

Use of Hyperpolarized 129Xe MR Lung Imaging in Infants

for
Lungs; Developmental Disorder
Location: Cincinnati OH
Sponsor: Children's Hospital Medical Center, Cincinnati

Sex: All

Age: 0

Code: NCT04995562

Recruiting

EXCEL: Technology and Exercise Adherence

for
Cancer
Location: Calgary
Sponsor: University of Calgary

Sex: All

Age: 19+

Code: NCT04790578

Recruiting

Study of Bevacizumab in Combination With Chemoimmunotherapy and Atezolizumab in Patients With Extensive Stage Small Cell Lung Cancer and Liver Metastases

for
Extensive-stage Small-cell Lung Cancer, Liver Metastases
Location: Ann Arbor MI, Los Angeles CA
Sponsor: Kamya Sankar

Sex: All

Age: 0+

Code: NCT05588388

Phase 2, Recruiting

Correlation Vitamin D Level to Endocrine Autoimmune Toxicity Due to Immune Checkpoint Inhibitors

for
Thyroid, PD-1, Cancer
Location: New York NY
Sponsor: Icahn School of Medicine at Mount Sinai

Sex: All

Age: 18+

Code: NCT04615988

Recruiting

Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer

for
Malignant Neoplasms of Respiratory and Intrathoracic Organs,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT03114462

Phase 1, Recruiting

Evaluation of an Algorithmically Enhanced Personalized Music-based Intervention on Stress Reduction in Cancer Patients

for
Cancer, Stress
Location: Boston MA
Sponsor: Rubato Life

Sex: All

Age: 18+

Code: NCT05519488

Recruiting

Study of CB307 in Patients With Advanced and/or Metastatic PSMA-positive Tumours.

for
Advanced and/or Metastatic Solid Tumours
Location: Seattle WA
Sponsor: Crescendo Biologics Ltd.

Sex: All

Age: 18+

Code: NCT04839991

Phase 1, Recruiting

Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases

for
Brain Metastases, Tumor
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05064280

Phase 2, Recruiting

A Prospective, Single Blinded Study for Predicting Colon Polyp Histology With Narrow Band Imaging

for
Colonoscopy, Adenomatous Polyp, Neoplastic
Location: Kansas City MO
Sponsor: Midwest Biomedical Research Foundation

Sex: All

Age: 18+

Code: NCT00613262

Recruiting

A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.

for
Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma,
Location: Fairfax VA, Pittsburgh PA, Canton OH, Columbus OH,
Sponsor: OncoNano Medicine, Inc.

Sex: All

Age: 18+

Code: NCT06022029

Phase 1, Recruiting

What is lung cancer?

Lung cancer starts when cells in the airways or lungs grow out of control. About 229,000 Americans will be diagnosed in 2026. There are two main types: non small cell lung cancer, about 85 percent of cases, and small cell lung cancer, which grows and spreads faster and is treated differently. Smoking causes most cases, but 10 to 20 percent happen in people who never smoked, from causes like radon, air pollution, or genetic changes. Most people are diagnosed around age 70.

Two things changed treatment. First, many lung cancers are driven by a single gene change, and pills that target that specific change can control the cancer for years, so tumors are now routinely tested for these changes before treatment starts. Second, immunotherapy works especially well in lung cancer, and some people with advanced disease are alive and well more than five years later. New targeted drugs kept getting approved through 2025, which is why lung cancer has more recruiting trials than any cancer except breast cancer.

Types of lung cancer clinical trials

Who can participate in lung cancer clinical trials?

What causes lung cancer?

Does vaping cause lung cancer?

The stages of lung cancer, and why they matter for trials

How to enroll in a lung cancer clinical trial